Retrospective Analysis of Treatment Patterns and the Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer

BACKGROUND: Cyclin-dependent kinase (CDK) 4/6 inhibitors are now standard of care for hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC). However, guidelines are lacking regarding their optimal sequencing with other available agents. This study aims to examine physician pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Compr Canc Netw
Main Authors: Xi, Jing, Oza, Aabha, Thomas, Shana, Naughton, Michael, Ademuyiwa, Foluso, Weilbaecher, Katherine, Suresh, Rama, Bose, Ron, Cherian, Mathew, Hernandez-Aya, Leonel, Frith, Ashley, Peterson, Lindsay, Luo, Jingqin, Krishnamurthy, Jairam, Ma, Cynthia X.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6752198/
https://ncbi.nlm.nih.gov/pubmed/30787127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jnccn.2018.7094
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados